3rd Annual Cardiac Safety Conference

Drug Information Association (DIA) is conducting an event called 3rd Annual Cardiac Safety Conference which will be held from 04th December 2008 in Barcelona, Spain.
 
Event Overview:
The rapid development of Cardiac Safety standards in clinical and drug development practices, coupled with the increased regulatory scrutiny, has resulted in a momentous evolution of the cardiac drug safety field. The ICH-E14 guidance has been at the centre of the public and industry interest since its inception in 2003. After its finalization in 2005, focus has shifted to regional interpretation and implementation of the guidance and the development of cardiac safety compliance strategies by biopharmaceutical and other organisations. The implementation of the E14 guidance has recently also been broadened to cover oncology drugs and biologics, with associated challenges in terms of e.g. finding alternatives to the ‘thorough QT study’ in healthy volunteers. Concomitantly, the field of Cardiac Drug Safety has expanded beyond the repolarisation and arrhythmia issues and is now involving wider areas of drug induced cardiotoxicity, including vascular and tissue related toxicities. These topics and other will be discussed at the forthcoming DIA Cardiac Safety meeting, alongside presentations of new technologies and novel biomarkers for early detection and risk management of drug related cardiac toxicity.
 
Target Audience:
• Drug Development and Clinical Research Managers
• Pharmaceutical Physicians/Medical Directors
• Drug Safety & Surveillance Personnel
• Pharmacovigilance Managers
• Regulatory Affairs Managers
• Quality Assurance Directors
• Preclinical Scientists
• ECG Safety Data Managers
• ECG Lab and Equipment Vendors
• Biostatisticians
• Data Managers
• IT Managers
• Outsourcing & Marketing Managers.

Can we request you to update the calendar of events on your website to include the details of this event? The details of the event are given below as well as attached. Please let me know if you need any further information.
 

  Event Name:   3rd Annual Cardiac Safety Conference   
  Event Date:   Dec 04 2008 - Dec 05 2008   
  Event Location:   Hilton Barcelona, Barcelona, Spain.   
  Event  Description:   The rapid development of Cardiac Safety standards in clinical and drug development practices, coupled with the increased regulatory scrutiny, has resulted in a momentous evolution of the cardiac drug safety field. The ICH-E14 guidance has been at the centre of the public and industry interest since its inception in 2003. After its finalization in 2005, focus has shifted to regional interpretation and implementation of the guidance and the development of cardiac safety compliance strategies by biopharmaceutical and other organisations. The implementation of the E14 guidance has recently also been broadened to cover oncology drugs and biologics, with associated challenges in terms of e.g. finding alternatives to the ‘thorough QT study’ in healthy volunteers. Concomitantly, the field of Cardiac Drug Safety has expanded beyond the repolarisation and arrhythmia issues and is now involving wider areas of drug induced cardiotoxicity, including vascular and tissue related toxicities. These topics and other will be discussed at the forthcoming DIA Cardiac Safety meeting, alongside presentations of new technologies and novel biomarkers for early detection and risk management of drug related cardiac toxicity.   
  Event Website:   http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17017&eventType=Meeting <http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17017&eventType=Meeting>   
  Contact Person:   Senior Manager of Marketing   
  Contact E-Mail ID:   talana.bertschi@diaeurope.org   
  Contact Phone:   +41 61 225 51 51   
  Contact Fax:   +41 61 225 51 52   
  Sponsoring Company Name:   Drug Information Association   
  Company Website:   http://www.diahome.org <http://www.diahome.org/>   
  Company Address:   Drug Information Association, European Branch Office, Basel, Switzerland.